Followers | 19 |
Posts | 6384 |
Boards Moderated | 2 |
Alias Born | 05/23/2019 |

Monday, May 05, 2025 6:22:54 PM
Latest News and Developments:
March 2025: CV Sciences, Inc. entered the plant-based food market with the launch of Lunar Fox Food Co., a new brand offering a range of plant-based, gluten-free products aimed at health-conscious consumers. The Lunar Fox lineup features innovative offerings such as CHEDDRLY MAC!, a vegan mac and cheese; WHISKED!, a plant-based egg substitute; and MANGIA!, a meatless alternative to beef inspired by Italian cuisine. The launch marks CV Sciences' strategic diversification beyond its core health and wellness portfolio into the growing plant-based food segment.
March 2025: Schouten Europe, a leading Dutch company in plant-based protein products, has introduced two new snacks, Power Bites and Sea Bites as part of its strategy to revive consumer interest in plant-based meat and fish alternatives. The launch comes amid a broader industry slowdown, with the company positioning these products to cater to evolving consumer preferences for healthier, sustainable, and convenient snack options. Schouten stated that this initiative aligns with its ongoing mission to bring innovation and renewed momentum to the plant-based food segment.
November 2024: Beyond Meat launched Beyond Sun Sausage™ nationwide at Whole Foods Market after a successful debut. Unlike traditional meat alternatives, it offers a unique plant-based protein made with spinach, bell peppers, and legumes. The Pesto flavor is available nationwide, with Cajun rolling out in select stores.
July 2024: UNLIMEAT launched its K-Vegan plant-based products in 149 GIANT and MARTIN'S stores. The lineup includes Korean BBQ Bulgogi, Pulled Pork, and frozen kimbap, catering to growing plant-based demand. This expansion brings authentic Korean-inspired vegan meals to the U.S. market.
March 2024: The Kraft Heinz Not Company LLC launched Oscar Mayer NotHotDogs and NotSausages, its first plant-based meat products. This marks the debut of plant-based Oscar Mayer offerings, combining Kraft Heinz and NotCo’s expertise. The new products deliver the classic savory, smoky flavor fans love.
March 2024: Chunk Foods, a biotechnology firm, launched a new range of plant-based meats, including a 6-oz steakhouse cut, 4-oz steak, and pulled meat. These products are crafted from cultured soy and wheat protein, providing a texture similar to traditional meat. Fortified with B12 and iron, they aim to offer a nutritious alternative for consumers seeking plant-based options.“

Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2025 09:03:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2025 01:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:28:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:27:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:27:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2025 10:04:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2024 09:17:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 09:38:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:06:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 02:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:54:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:28:43 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM